Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Arrowhead Research
ARWR
$12.5B
| $23.6M | ﹤0.01% |
1,848,536
+312,124
| +20% | +$5.68M |
|
2527
Xeris Biopharma Holdings
XERS
$1.46B
| $23.5M | ﹤0.01% |
4,288,281
+1,410,765
| +49% | +$5.69M |
|
2528
United Parks & Resorts
PRKS
$2B
| $23.5M | ﹤0.01% |
517,723
-49,883
| -9% | -$2.58M |
|
2529
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.12B
| $23.5M | ﹤0.01% |
220,085
-19,662
| -8% | -$2.26M |
|
2530
Pulmonx
LUNG
$97.9M
| $23.5M | ﹤0.01% |
3,494,129
+421,291
| +14% | +$2.98M |
|
2531
Customers Bancorp
CUBI
$2.78B
| $23.5M | ﹤0.01% |
468,330
-23,094
| -5% | -$1.21M |
|
|
ETV
2532
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.77B
| $23.5M | ﹤0.01% |
1,775,298
-78,243
| -4% | -$1.1M |
|
2533
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.36B
| $23.4M | ﹤0.01% |
254,718
+24,162
| +10% | +$2.32M |
|
2534
MidCap Financial Investment
MFIC
$797M
| $23.4M | ﹤0.01% |
1,823,054
+283,008
| +18% | +$3.85M |
|
2535
Taysha Gene Therapies
TSHA
$1.83B
| $23.4M | ﹤0.01% |
16,846,374
-793,992
| -5% | -$1.33M |
|
2536
St. Joe Company
JOE
$3.77B
| $23.4M | ﹤0.01% |
498,217
-29,712
| -6% | -$1.39M |
|
2537
Mercury Systems
MRCY
$6.52B
| $23.4M | ﹤0.01% |
542,840
+27,579
| +5% | +$1.21M |
|
2538
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
| $23.4M | ﹤0.01% |
496,438
+53,254
| +12% | +$2.52M |
|
2539
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
| $23.3M | ﹤0.01% |
787,949
+125,730
| +19% | +$3.69M |
|
2540
Texas Capital Bancshares
TCBI
$4.32B
| $23.3M | ﹤0.01% |
311,937
-98,968
| -24% | -$7.69M |
|
|
HUT
2541
Hut 8
HUT
$10.6B
| $23.3M | ﹤0.01% |
2,001,113
+305,092
| +18% | +$5.63M |
|
2542
Arbor Realty Trust
ABR
$1,000M
| $23.2M | ﹤0.01% |
1,973,135
-84,900
| -4% | -$1.1M |
|
2543
Cadre Holdings
CDRE
$1.4B
| $23.2M | ﹤0.01% |
782,686
-24,825
| -3% | -$855K |
|
2544
City Holding Co
CHCO
$2.04B
| $23.2M | ﹤0.01% |
197,160
-23,328
| -11% | -$2.75M |
|
2545
Schrodinger
SDGR
$1.4B
| $23.2M | ﹤0.01% |
1,172,945
-368,776
| -24% | -$8.3M |
|
2546
CG Oncology
CGON
$6.79B
| $23.1M | ﹤0.01% |
945,081
+219,854
| +30% | +$6.18M |
|
2547
PBF Energy
PBF
$7.86B
| $23.1M | ﹤0.01% |
1,211,189
+15,520
| +1% | +$386K |
|
2548
Biohaven
BHVN
$2.19B
| $23.1M | ﹤0.01% |
958,913
+176,256
| +23% | +$6.22M |
|
2549
First Trust Europe AlphaDEX Fund
FEP
$531M
| $23M | ﹤0.01% |
563,970
+39,411
| +8% | +$1.54M |
|
2550
iShares Morningstar Small-Cap Value ETF
ISCV
$704M
| $23M | ﹤0.01% |
387,730
-11,650
| -3% | -$733K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.